QSS
OCRX

Quantitative Systematic Strategies’s Ocera Therapeutics, Inc. OCRX Stock Holding History

Quantitative Systematic Strategies’s Portfolio OCRX Stock Details OCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-13,548
Closed -$42K – 946
2015
Q4 		$42K Buy
+13,548
New +$46.3K 0.01% 872

Other funds holding OCRX

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
VMI
VHCP Management II New York $379M AUM 421.62% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
VM
VHCP Management New York $93M AUM 10.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
TI
Turner Investments Berwyn, Pennsylvania $134K AUM 49.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
WMSA
Weiss Multi-Strategy Advisers New York $4.16B AUM 30.77% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Quantitative Systematic Strategies's OCRX Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Ocera Therapeutics, Inc. (OCRX) in Q1 2016, closing a stake of 13,548 shares — an estimated $42K sold.

Quantitative Systematic Strategies first reported a position in OCRX in Q4 2015 and held it in 1 quarter. The position peaked at $42K in Q4 2015. 33 funds tracked by Wall St. Rank hold OCRX as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Ocera Therapeutics, Inc. position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 13,548 Ocera Therapeutics, Inc. shares in Q1 2016, an estimated $42K.
  • Quantitative Systematic Strategies first reported a position in Ocera Therapeutics, Inc. in Q4 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Ocera Therapeutics, Inc. position peaked at $42K in Q4 2015.
  • 33 funds tracked by Wall St. Rank held Ocera Therapeutics, Inc. as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.